Anyone have an idea what kind of valuation we would be looking at if we get positive results on depression and cognition next quarter?
Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis, page-50
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.001(3.85%) |
Mkt cap ! $79.51M | |||
| Open | High | Low | Value | Volume |
| 2.6¢ | 2.7¢ | 2.6¢ | $47.08K | 1.745M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 1931385 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 2926510 | 8 |
View Market Depth
| Last trade - 15.50pm 16/10/2024 (20 minute delay) ? |
| ACW (ASX) Chart |